Centro Hepato-Bilio-Pancreático e de Transplantação
Permanent URI for this community
Browse
Browsing Centro Hepato-Bilio-Pancreático e de Transplantação by Author "Aires, I"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- Predicting Function Delay with a Machine Learning Model: Improve the Long-term Survival of Pancreatic GraftsPublication . Vigia, E; Ramalhete, L; Barros, I; Chumbinho, B; Filipe, E; Pena, A; Bicho, L; Nobre, A; Carrelha, S; Corado, S; Sobral, M; Lamelas, J; Santos Coelho, J; Pinto Marques, H; Pico, P; Costa, S; Rodrigues, F; Bigotte Vieira, M; Magriço, R; Cotovio, P; Caeiro, F; Aires, I; Silva, C; Remédio, F; Martins, A; Ferreira, A; Paulino, J; Nolasco, F; Ribeiro, RThe impact of delayed graft function on outcomes following various solid organ transplants is well documented and addressed in the literature. Delayed graft function following various solid organ transplants is associated with both short- and long-term graft survival issues. In a retrospective cohort study including 106 patients we evaluated whether pancreas graft survival differs according to moment of insulin therapy following simultaneous pancreaskidney transplant. As a result, we aimed to identify possible risk factors and build a machine-learning-based model that predicts the likelihood of dysfunction following SPK transplant patients based on day zero data after transplant, allowing to enhance pancreatic graft survival. Feature selection by Relief algorithm yielded donor features, age, cause of death, hemoglobin, gender, ventilation days, days in ICU, length of cardiac respiratory arrest and recipient features, gender, long-term insulin, dialysis type, time of diabetes mellitus, vPRA pre-Tx, number of HLA-A mismatches and PRDI, all contributed to the models' strength.
- Sirolimus-Induced Drug Fever in a Renal Transplant Patient: a Case ReportPublication . Aires, I; Carvalho, D; Remédio, F; Possante, M; Ferreira, A; Pinto, JR; Nolasco, F; Ribeiro Santos, JHerein we have described the case of a male renal transplant recipient who developed drug fever apparently related to sirolimus. He had been stable under an immunosuppressive regimen of tacrolimus and mycophenolate mofetil, but developed acute cellular rejection at 5 years after transplantation due to noncompliance. Renal biopsy showed marked interstitial fibrosis, and immunosuppression was switched from mycophenolate to sirolimus, maintaining low tacrolimus levels. One month later he was admitted to our hospital for investigation of intermittently high fever, fatigue, myalgias, and diarrhea. Physical examination was unremarkable and drug levels were not increased. Lactic dehydrogenase and C-reactive protein were increased. The blood cell count and chest radiographic findings were normal. After extensive cultures, he was started on broad-spectrum antibiotics. Inflammatory markers and fever worsened, but diarrhea resolved. All serologic and imaging tests excluded infection, immune-mediated diseases, and malignancy. After 12 days antibiotics were stopped as no clinical improvement was achieved. Drug fever was suspected; sirolimus was replaced by mycophenolate mofetil. Fever and other symptoms disappeared after 24 hours; inflammatory markers normalized in a few days. After 1 month the patient was in good health with stable renal function. Although infrequent, the recognition of drug fever as a potential side effect of sirolimus may avoid unnecessary invasive diagnostic procedures. Nevertheless, exclusion of other common causes of fever is essential.